<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Main sections on MARIO-MICCAI 2024</title>
    <link>//localhost:1313/docs/compose/</link>
    <description>Recent content in Main sections on MARIO-MICCAI 2024</description>
    <generator>Hugo</generator>
    <language>en</language>
    <atom:link href="//localhost:1313/docs/compose/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>üóÇÔ∏è Data</title>
      <link>//localhost:1313/docs/compose/data/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/data/</guid>
      <description>&lt;h2 id=&#34;data-sources-characteristics&#34;&gt;Data source(s) characteristics&lt;/h2&gt;&#xA;&lt;p&gt;Imaging data was acquired with a Spectralis OCT device (Heidelberg Engineering). B-scan definition was 496x1024 pixels; the number of B-scans per C-scan was patient dependent (typically 49 B- scans). Consecutive examinations were registered using the Spectralis follow-up option. The data was exported in XML+bitmap format using the Spectralis software version 6.9.4.0. Data was collected at the Ophthalmology department of Brest University Hospital (France). All patients are followed-up for monitoring and treatment of vascular AMD. Imaging data was collected by ophthalmologists (retina specialists).&lt;/p&gt;</description>
    </item>
    <item>
      <title> üîé Evaluation and Ranking</title>
      <link>//localhost:1313/docs/compose/evaluation/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/evaluation/</guid>
      <description>&lt;h3 id=&#34;for-task-1&#34;&gt;For task 1&lt;/h3&gt;&#xA;&lt;p&gt;The following metrics will be used in the leader board for both phase of task 1&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;F1-score,&lt;/li&gt;&#xA;&lt;li&gt;Specificity,&lt;/li&gt;&#xA;&lt;li&gt;Rk-correlation coefficient (RkC)&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 id=&#34;for-task-2&#34;&gt;For task 2&lt;/h3&gt;&#xA;&lt;p&gt;The following metrics will be used in the leader board for both phase of task 2&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;F1-score&lt;/li&gt;&#xA;&lt;li&gt;Specificity&lt;/li&gt;&#xA;&lt;li&gt;Rk-correlation coefficient (RkC)&lt;/li&gt;&#xA;&lt;li&gt;Quadratic weighted Kappa&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;hr&gt;&#xA;&lt;h2 id=&#34;httpsencrypted-tbn0gstaticcomimagesqtbnand9gctkx6fvxz3dsf0njh5dm24l__x1l0zs3zkvequsqpcauranking-methods&#34;&gt;&lt;img src=&#34;https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTkx6FVxZ3dsF0NJh5Dm24l__x1l0ZS3zkVEQ&amp;usqp=CAU&#34;&gt;Ranking method(s)&lt;/h2&gt;&#xA;&lt;h5 id=&#34;_only-participants-with-comprehensive-results-for-the-task-will-appear-in-the-final-ranking_&#34;&gt;&lt;em&gt;Only participants with comprehensive results for the task will appear in the final ranking.&lt;/em&gt;&lt;/h5&gt;&#xA;&lt;h5 id=&#34;_in-the-final-ranking-task-2-will-be-given-a-higher-weight-as-it-is-the-most-challenging-and-clinically-useful-task_&#34;&gt;&lt;em&gt;In the final ranking, task 2 will be given a higher weight as it is the most challenging and clinically useful task.&lt;/em&gt;&lt;/h5&gt;</description>
    </item>
    <item>
      <title>1Ô∏è‚É£üéØ Task 1</title>
      <link>//localhost:1313/docs/compose/task1/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/task1/</guid>
      <description>&lt;h1 id=&#34;task-1-classify-evolution-between-two-pairs-of-2-d-slices-from-two-consecutive-2d-oct-acquisitions&#34;&gt;TASK 1: Classify evolution between two pairs of 2-D slices from two consecutive 2D OCT acquisitions.&lt;/h1&gt;&#xA;&lt;ol&gt;&#xA;&lt;li&gt;The first task focuses on pairs of 2D slices (B-scans) from two consecutive OCT acquisitions. The goal is to classify the evolution between these two slices (before and after), which clinicians typically examine side by side on their screens.&lt;img src=&#34;../../../images/mario_task_1_gray_bg.png&#34;&gt;&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;p&gt;For evolution assessment between two consecutives examination (Task 1), the following fo classes are defined.&lt;/p&gt;</description>
    </item>
    <item>
      <title>2Ô∏è‚É£üéØ Task 2</title>
      <link>//localhost:1313/docs/compose/task2/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/task2/</guid>
      <description>&lt;h1 id=&#34;task-2-prediction-of-evolution-within-3-mounts-of-amd-on-oct-2d-slices-for-planning-treatment-anti-vegf&#34;&gt;TASK 2: Prediction of evolution within 3 mounts of AMD on OCT 2D slices for planning treatment anti-VEGF.&lt;/h1&gt;&#xA;&lt;ol start=&#34;2&#34;&gt;&#xA;&lt;li&gt;The second task focuses on 2D slices level. The goal is to predict the future evolution within 3 months with close monitoring of patients that are enrolled in an anti-VEGF treatments plan.&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;p&gt;&lt;img src=&#34;../../../images/mario_task_2_gray_bg.png&#34;&gt;&lt;/p&gt;&#xA;&lt;p&gt;For the prediction of the evolution within 3 months (Task 2), the following fo classes are defined:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;REDUCED: 0 = ELIMINATED: 1 or PERSISTENT_REDUCED: 2&lt;/li&gt;&#xA;&lt;li&gt;STABLE: 1  = INACTIVE: 0 or PERSISTENT_STABLE: 3&lt;/li&gt;&#xA;&lt;li&gt;WORSENED: 2 = PERSISTENT_WORSENED: 4 or APPEARED: 6&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;Like it is illustrated we provide to participants along side with the OCT for each visit an localizers and some clinical data. We encourage the participants to develop multi-modal method to takle this task. &lt;strong&gt;It should be noted that the minimun input expected for your algoritm development should be at least the OCT B-scan.&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>üìÉ Challenge papers</title>
      <link>//localhost:1313/docs/compose/challenge_paper/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/challenge_paper/</guid>
      <description>&lt;h3 id=&#34;challenge-papers&#34;&gt;Challenge papers&lt;/h3&gt;&#xA;&lt;p&gt;To ensure transparency and reproducibility, we require participants to submit a brief method description alongside their final test set results. This description should follow the Springer Lecture Notes in Computer Science (LNCS) format.¬† An Overleaf template is available¬†¬†&lt;a href=&#34;https://www.overleaf.com/latex/templates/springer-lecture-notes-in-computer-science/kzwwpvhwnvfj&#34;&gt;template&lt;/a&gt;¬†to facilitate this process.&lt;/p&gt;&#xA;&lt;p&gt;The paper description should focus on the key steps involved in developing your submitted approach.¬† Here are some recommended elements to¬† include:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Introduction&lt;/li&gt;&#xA;&lt;li&gt;Method¬† ¬†&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Pre-processing&lt;/li&gt;&#xA;&lt;li&gt;Proposed method&lt;/li&gt;&#xA;&lt;li&gt;Pre-training (if any)&lt;/li&gt;&#xA;&lt;li&gt;Post-processing (if any)&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;Results&lt;/li&gt;&#xA;&lt;li&gt;Discussion&lt;/li&gt;&#xA;&lt;li&gt;Link to public code repository&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;You can submit one paper for both tasks, or separate papers for each task. The choice is yours.&lt;/p&gt;</description>
    </item>
    <item>
      <title>üë• Organizers</title>
      <link>//localhost:1313/docs/compose/organizer/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/organizer/</guid>
      <description>&lt;h5 id=&#34;alphabetical-order&#34;&gt;¬†(Alphabetical order)&lt;/h5&gt;&#xA;&lt;h2 id=&#34;httpscdn-icons-pngflaticoncom641060010600860png-team-organizers&#34;&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/64/10600/10600860.png&#34;&gt; Team Organizers¬†&lt;/h2&gt;&#xA;&lt;h3 id=&#34;technical&#34;&gt;Technical&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Alireza Rezaei &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn1&#34;&gt;1&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Gwenol√© Quellec &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Mathieu Lamard &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn1&#34;&gt;1&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Mostafa El Habib Daho &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn1&#34;&gt;1&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Pierre-Henri Conze &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn3&#34;&gt;3&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Rachid Zeghlache &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn1&#34;&gt;1&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 id=&#34;medical&#34;&gt;Medical&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Anas-Alexis Benyoussef &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn4&#34;&gt;4&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;B√©atrice Cochener &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn1&#34;&gt;1&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn2&#34;&gt;2&lt;/a&gt; &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn4&#34;&gt;4&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Thomas Monfort &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn4&#34;&gt;4&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;hr&gt;&#xA;&lt;h2 id=&#34;httpscdn-icons-pngflaticoncom641398013980234png-team-organizers&#34;&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/64/13980/13980234.png&#34;&gt;¬† Team Organizers&lt;/h2&gt;&#xA;&lt;h3 id=&#34;technical-1&#34;&gt;Technical&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Leila Ryma Lazouni &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn5&#34;&gt;5&lt;/a&gt;&lt;/li&gt;&#xA;&lt;li&gt;Mohammed El Amine Lazouni¬†&lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn5&#34;&gt;5&lt;/a&gt;&lt;/li&gt;&#xA;&lt;li&gt;Zineb Aziza Elaouaber¬†&lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn5&#34;&gt;5&lt;/a&gt;¬†&lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn6&#34;&gt;6&lt;/a&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 id=&#34;medical-1&#34;&gt;Medical&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Sofiane Zehar &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn6&#34;&gt;6&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Karim Boukli Hacene &lt;a href=&#34;//localhost:1313/docs/compose/organizer/#fn6&#34;&gt;6&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;hr&gt;&#xA;&lt;ol&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Univ Bretagne Occidentale, Brest, F-29200 France&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Inserm, UMR 1101, Brest, F-29200 France&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;IMT Atlantique, Brest, F-29200 France¬†&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;Service d‚ÄôOphtalmologie, CHRU Brest, Brest, F-29200 France&lt;/p&gt;</description>
    </item>
    <item>
      <title>üèÜ Prizes</title>
      <link>//localhost:1313/docs/compose/prizes/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/prizes/</guid>
      <description>&lt;h4 id=&#34;_the-challenges-offer-the-following_-awards&#34;&gt;&lt;strong&gt;&lt;em&gt;The challenges offer the following&lt;/em&gt; awards&lt;/strong&gt;&lt;/h4&gt;&#xA;&lt;ol&gt;&#xA;&lt;li&gt;The top ten performing teams will¬†be invited to participate in a challenge paper. The top-5 teams can have up to 5 co-authors each, while the 6th to¬†10th place teams can have up to 3 co-authors each. In the paper, we will publish a substantial summary of the¬†challenge results.&lt;/li&gt;&#xA;&lt;li&gt;Thank to the initiative of the &lt;a href=&#34;https://basira-lab.com/&#34;&gt;BASIRA&lt;/a&gt;¬†lab¬† and in collaboration with &lt;a href=&#34;https://basira-lab.com/prime-miccai-2024/&#34;&gt;MICCAI PRIME&lt;/a&gt; Workshop.¬† All the teams that made to final phase will have the opportunities to have their challenge paper published¬† in the International Workshop on PRedictive Intelligence In MEdicine Part of the book series: Lecture Notes in Computer Science (LNCS). For more detail please refer to the following &lt;a href=&#34;https://youvenz.github.io/MARIO_challenge.github.io/docs/compose/challenge_paper/&#34;&gt;page&lt;/a&gt;.¬† ¬†&lt;/li&gt;&#xA;&lt;li&gt;The top 5 teams will received a certificate of achievement.&lt;/li&gt;&#xA;&lt;li&gt;ü§ë¬†Also we currently seeking for sponsor to secure cash prize money for the top 3 teams ü§ë.&lt;/li&gt;&#xA;&lt;/ol&gt;&#xA;&lt;hr&gt;&#xA;&lt;p&gt;&lt;img src=&#34;../../../images/sponsors.png&#34;&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>üìú Rules</title>
      <link>//localhost:1313/docs/compose/rules/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/rules/</guid>
      <description>&lt;hr&gt;&#xA;&lt;p&gt;There several policies that participant are required to consider in order to be included in the competition:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;All final submissions should be in the form of docker containers and follow the provided template provided by the organizers to be tested successfully.&lt;/li&gt;&#xA;&lt;li&gt;Only &lt;strong&gt;fully automated methods&lt;/strong&gt; are acceptable for participation in this challenge as the submission is in the form of docker containers. It is not possible to submit manual annotations or interactive methods.&lt;/li&gt;&#xA;&lt;li&gt;Submissions will be ranked solely based on their performance on the final test set and according to the criteria explained in the &lt;a href=&#34;https://youvenz.github.io/MARIO_challenge.github.io/docs/compose/evaluation/&#34;&gt;evaluation&lt;/a&gt; page.&lt;/li&gt;&#xA;&lt;li&gt;Using pre-trained models on general purpose datasets (like ImageNet) is allowed.&lt;/li&gt;&#xA;&lt;li&gt;Use of &lt;strong&gt;external&lt;/strong&gt;¬†&lt;strong&gt;data&lt;/strong&gt; for model development is not &lt;strong&gt;permitted&lt;/strong&gt;.&lt;/li&gt;&#xA;&lt;li&gt;Writing a technical paper for final submission is compulsory, otherwise the submission will not be considered.&lt;/li&gt;&#xA;&lt;li&gt;Users/teams can have multiple submissions on the preliminary test set to verify the quality of their methods. However, the number of submissions per day per user and for each task is limited to 2 in order to restrict test data hacking.&lt;/li&gt;&#xA;&lt;li&gt;For the final test set, only 2 submission is allowed for each user/team.&lt;/li&gt;&#xA;&lt;li&gt;Users can form a team and participate together. Teams can have different submissions as long as their submissions vary considerably based on the described methodology in their technical papers. Otherwise, organizers have the right to disqualify those submissions at their discretion.&lt;/li&gt;&#xA;&lt;li&gt;Members from the organizing team can participate in this challenge. If there is a method in the leaderboard submitted by the organizers, that method will not be taken into account for the final ranking&lt;/li&gt;&#xA;&lt;li&gt;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 id=&#34;httpscdn-icons-pngflaticoncom641104311043224pnglicence-&#34;&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/64/11043/11043224.png&#34;&gt;¬†Licence :&lt;/h3&gt;&#xA;&lt;p&gt;The data can only be used for the purpose and duration of the challenge. It cannot be distributed. As we did for previous challenges (&lt;a href=&#34;https://ieee-dataport.org/open-access/cataracts&#34;&gt;https://ieee-dataport.org/open-access/cataracts&lt;/a&gt;), data will be released publicly after the challenge paper is accepted, under the terms of the ‚ÄúCreative Commons‚Äù Attribution&lt;br&gt;&#xA;(CC-BY) license.&lt;/p&gt;</description>
    </item>
    <item>
      <title>üóì Important Dates</title>
      <link>//localhost:1313/docs/compose/important_date/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/important_date/</guid>
      <description>&lt;p&gt;The following information outlines a proposed timeline for the challenge, subject to adjustments based on the MICCAI 2024 schedule and the organizers&#39; assessment to guarantee the quality of the challenge.&lt;/p&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/32/1497/1497835.png&#34;&gt;¬†¬†Registration Period:&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;April 1, 2024 - July 10, 2024&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/32/1981/1981523.png&#34;&gt;¬†¬†Release of Training and Off-site Validation Data (Without Labels):&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;May 2, 2024&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/32/11725/11725639.png&#34;&gt;¬†Off-site Result Submission Period:&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;May 2, 2024 - July 31, 2024&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://cdn-icons-png.flaticon.com/32/1378/1378644.png&#34;&gt;¬†Announcement of Finalists:&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;August 1, 2024&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title></title>
      <link>//localhost:1313/docs/compose/announcement/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>//localhost:1313/docs/compose/announcement/</guid>
      <description>&lt;p&gt;Comming soon ! Stay tuned&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
